Detailed information for compound 1823155

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 696.789 | Formula: C39H44N4O8
  • H donors: 1 H acceptors: 3 LogP: 2.52 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 2
  • SMILES: CON1c2ccccc2[C@@]2(C1=O)C[C@@H]1N=C([C@@H]3C[C@H]2OC[C@H]13)[C@@](C[C@H]([C@]12ON2[C@@H]2[C@@H]3[C@H]1C[C@@H](OC3)[C@]1(C2)c2ccccc2N(C1=O)OC)C)(O)C
  • InChi: 1S/C39H44N4O8/c1-20(39-26-14-32-38(17-30(43(39)51-39)23(26)19-50-32)25-10-6-8-12-29(25)42(48-4)35(38)45)15-36(2,46)33-21-13-31-37(16-27(40-33)22(21)18-49-31)24-9-5-7-11-28(24)41(47-3)34(37)44/h5-12,20-23,26-27,30-32,46H,13-19H2,1-4H3/t20-,21-,22+,23+,26-,27+,30+,31-,32-,36-,37+,38+,39+,43?/m1/s1
  • InChiKey: QNSZKXIWPRPXNZ-CPYLQPPWSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trichomonas vaginalis glucosylceramidase, putative 0.0182 0.2447 0.6291
Plasmodium vivax AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative 0.002 0.0196 0.5
Trichomonas vaginalis glucosylceramidase, putative 0.0278 0.3775 1
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.01 0.1306 0.1133
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.01 0.1306 0.1133
Trypanosoma cruzi apurinic/apyrimidinic endonuclease, putative 0.002 0.0196 1
Trichomonas vaginalis glucosylceramidase, putative 0.0182 0.2447 0.6291
Trypanosoma cruzi apurinic/apyrimidinic endonuclease 0.002 0.0196 1
Trichomonas vaginalis glucosylceramidase, putative 0.0278 0.3775 1
Brugia malayi GTP-binding regulatory protein Gs alpha-S chain, putative 0.01 0.1306 0.3104
Loa Loa (eye worm) GTP-binding regulatory protein Gs alpha-S chain 0.01 0.1306 0.3104
Trichomonas vaginalis glucosylceramidase, putative 0.0278 0.3775 1
Trichomonas vaginalis glucosylceramidase, putative 0.0278 0.3775 1
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.01 0.1306 0.1133
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.01 0.1306 0.1133
Trichomonas vaginalis glucosylceramidase, putative 0.0182 0.2447 0.6291
Wolbachia endosymbiont of Brugia malayi exonuclease III 0.002 0.0196 0.5
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.01 0.1306 0.1133
Trichomonas vaginalis glucosylceramidase, putative 0.0192 0.2584 0.6672
Loa Loa (eye worm) O-glycosyl hydrolase family 30 protein 0.0278 0.3775 1
Trichomonas vaginalis glucosylceramidase, putative 0.0192 0.2584 0.6672
Brugia malayi O-Glycosyl hydrolase family 30 protein 0.0278 0.3775 1
Entamoeba histolytica protein kinase, putative 0.0726 1 1
Entamoeba histolytica protein kinase, putative 0.0726 1 1
Schistosoma mansoni serine/threonine protein kinase 0.0726 1 1
Trichomonas vaginalis glucosylceramidase, putative 0.0278 0.3775 1
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.01 0.1306 0.1133
Toxoplasma gondii exonuclease III APE 0.002 0.0196 0.5
Trichomonas vaginalis glucosylceramidase, putative 0.0182 0.2447 0.6291
Treponema pallidum exodeoxyribonuclease (exoA) 0.002 0.0196 0.5
Trichomonas vaginalis glucosylceramidase, putative 0.0182 0.2447 0.6291
Onchocerca volvulus Glucosylceramidase homolog 0.0182 0.2447 0.5
Mycobacterium tuberculosis Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) 0.002 0.0196 0.5
Echinococcus granulosus calcium:calmodulin dependent protein kinase I 0.0726 0.9996 0.9996
Leishmania major apurinic/apyrimidinic endonuclease-redox protein 0.002 0.0196 1
Trypanosoma brucei apurinic/apyrimidinic endonuclease, putative 0.002 0.0196 1
Echinococcus multilocularis serine:threonine protein kinase Chk2 0.0726 1 1
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.01 0.1306 0.1133
Giardia lamblia Endonuclease/Exonuclease/phosphatase 0.002 0.0196 0.5
Trichomonas vaginalis glucosylceramidase, putative 0.0182 0.2447 0.6291
Mycobacterium ulcerans exodeoxyribonuclease III protein XthA 0.002 0.0196 0.5
Trichomonas vaginalis glucosylceramidase, putative 0.0182 0.2447 0.6291
Trichomonas vaginalis glucosylceramidase, putative 0.0278 0.3775 1
Echinococcus multilocularis calcium:calmodulin dependent protein kinase I 0.0726 0.9996 0.9996
Plasmodium falciparum AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative 0.002 0.0196 0.5
Entamoeba histolytica exodeoxyribonuclease III, putative 0.002 0.0196 0.0196

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.